1144 related articles for article (PubMed ID: 31484464)
1. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
3. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
4. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors.
Cavallari C; Camussi G; Brizzi MF
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942702
[TBL] [Abstract][Full Text] [Related]
6. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
8. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
Yu YR; Ho PC
Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.
Tuccitto A; Shahaj E; Vergani E; Ferro S; Huber V; Rodolfo M; Castelli C; Rivoltini L; Vallacchi V
Virchows Arch; 2019 Apr; 474(4):407-420. PubMed ID: 30374798
[TBL] [Abstract][Full Text] [Related]
11. [Immune cell contexture in the tumor microenvironment].
Fujii SI
Rinsho Ketsueki; 2020; 61(9):1424-1432. PubMed ID: 33162545
[TBL] [Abstract][Full Text] [Related]
12. The updated landscape of tumor microenvironment and drug repurposing.
Jin MZ; Jin WL
Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
[TBL] [Abstract][Full Text] [Related]
13. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
14. CD8
Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.
Cao H; Huang T; Dai M; Kong X; Liu H; Zheng Z; Sun G; Sun G; Rong D; Jin Z; Tang W; Xia Y
Int J Biol Sci; 2022; 18(14):5369-5390. PubMed ID: 36147461
[TBL] [Abstract][Full Text] [Related]
16. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
17. Immune Landscape of Thyroid Cancers: New Insights.
Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
[TBL] [Abstract][Full Text] [Related]
18. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.
Wang JX; Choi SYC; Niu X; Kang N; Xue H; Killam J; Wang Y
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171818
[TBL] [Abstract][Full Text] [Related]
19. Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.
Guo G; Yu M; Xiao W; Celis E; Cui Y
Cancer Res; 2017 May; 77(9):2292-2305. PubMed ID: 28280037
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
